Global Dry Powder Inhaler Market Outlook 2018-2023

Global Dry Powder Inhaler Market is projected to display significant growth in the coming years due to increase in number of respiratory disorders. Dry powder inhaler (DPI) is the commonly used inhaler for respiratory disorders, such as bronchitis, asthma, (COPD) Chronic Obstructive Pulmonary Disease, and emphysema. Medication is released form the inhaler when the patient takes fast and deep breaths. Some of the commonly used dry powder inhalers are; Asmanex, Advair Diskus, and Pulmicort flexhaler.

The major driving factors of dry powder inhaler market comprise growing concern among patients for accurate dosage, increase in geriatric population, and rise in number of technological innovations in the product. Moreover, high exposure to chemicals and smoke due to industrial releases and air pollution, unhealthy lifestyle on the global scale, and speedy urbanization is expected to propel the market. Conversely, low awareness for dry powder inhalers is expected to hamper the market.

Increasing focus of manufacturers for applying new techniques like (CFD) computational fluid dynamics for the advancement of the novel products is an opportunity for the market. Additionally, untapped regions across the globe is also expected to create opportunity for the market players to expand their customer base.  

Dry powder inhaler market is categorized on the basis of product type, application, distribution channel, and geography. On the basis of product type, market is divided into multi dose dry powder inhaler and single dose dry powder inhaler. Single dose dry powder inhalers are expected to hold significant share of the market in future owing to high prevalence of respiratory and pulmonary diseases. Moreover, high concentration of toxic compounds and growing number of allergens is causing asthma and other respiratory infections. These inhalers are gaining popularity in the emerging nations due to low prices.

In terms of application, dry powder inhaler market is divided into pulmonary arterial hypertension, asthma, chronic obstructive pulmonary disease, respiratory disorders, and others. Arterial hypertension, asthma, and respiratory diseases segments are the common disorders observed in developing economies. Hence, the use of dry powder inhalers are ideal for these applications, since they offer accurate and sufficient dosage to the patients.

Based on distribution channel, dry powder inhaler market is divided into drug stores, hospitals and pharmacies, online pharmacies, and retail pharmacies. Hospitals and pharmacies segment is predicted to lead the market in the near future due to rise in adoption rate by the physicians. Additionally, easy availability of dry powder inhalers in the pharmacies is also contributing significantly to the segment growth.

Geographically, dry powder inhaler market is segmented as North America, South America, Europe, Asia Pacific, and Middle East & Africa. North America is estimated to dominate the market owing to growing geriatric population, high prevalence of asthma and other respiratory disorders, and increase in adoption of novel technologies. Moreover, Asia Pacific is expected to contribute substantially due to growing number of allergies.

The leading players in dry powder inhaler market include GlaxoSmithKline Plc., Cipla Inc., Teicos Pharma Ltd., Beximco Pharma Ltd., Presspart Manufacturing Ltd., SRS Pharmaceuticals Pvt. Ltd., Catalent, Inc., AstraZeneca Plc., Hovione FarmaCiencia SA., Bespak Europe Ltd., and Luckys Pharma.

Global Market for dry powder inhaler to 2023 offers detailed coverage of dry powder inhaler industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading dry powder inhaler producers to provide exhaustive coverage of the dry powder inhaler.

Report contents include
- Analysis of the dry powder inhaler market including revenues, future growth, market outlook
- Historical data and forecast
- Regional analysis including growth estimates
- Analyzes the end user markets including growth estimates.
- Profiles on dry powder inhaler including products, sales/revenues, and market position
- Market structure, market drivers and restraints.

Key regions
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America

Key Vendors
- request free sample to get a complete list of companies